Patents by Inventor Edward H. Kerns

Edward H. Kerns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified lysine-mimetic compounds
    Patent number: 8431540
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: April 30, 2013
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • MODIFIED LYSINE-MIMETIC COMPOUNDS
    Publication number: 20120245106
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Application
    Filed: September 16, 2011
    Publication date: September 27, 2012
    Applicant: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • Modified lysine-mimetic compounds
    Patent number: 8026272
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: September 27, 2011
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • MODIFIED LYSINE-MIMETIC COMPOUNDS
    Publication number: 20100249206
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Application
    Filed: October 30, 2009
    Publication date: September 30, 2010
    Inventors: Bjarne Due Larsen, Jorgen Soberg Petersen, Ketil Jorgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • N- or C- terminally modified small peptides
    Patent number: 7749969
    Abstract: N- or C-terminally modified small peptides having antiarrhythmic properties are disclosed, and in particular small peptides that possess improved pharmacokinetic properties such as having a reduced tendency to inhibit the activity of isozyme 3A4 of cytochrome P 450 oxidase. The invention further relates to uses of said compounds in the preparation of a medicament, and to pharmaceutical compositions comprising said compounds.
    Type: Grant
    Filed: July 7, 2006
    Date of Patent: July 6, 2010
    Assignees: Zealand Pharma A/S, Wyeth
    Inventors: Bjarne Due Larsen, Edward H. Kerns
  • Modified lysine-mimetic compounds
    Patent number: 7622496
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 24, 2009
    Assignees: Zealand Pharma A/S, Wyeth
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni L. Piatnitski